Home > Healthcare > Pharmaceuticals > Clinical Nutrition > Clinical Nutrition for Diabetes Care Market

Clinical Nutrition for Diabetes Care Market Share

Report ID: GMI10070
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Clinical Nutrition for Diabetes Care Market Share

The clinical nutrition for diabetes care industry is competitive and dynamic, driven by innovation, expanding global diabetes prevalence, regulatory compliance, and strategic initiatives by key players. Major companies in the market include Abbott Laboratories, Nestle Health Science, Danone Nutricia, and B. Braun Melsungen AG, among others. These companies dominate the market through extensive product portfolios, global distribution networks, and strategic alliances.

Clinical Nutrition for Diabetes Care Market Companies

Prominent players operating in the clinical nutrition for diabetes care industry include:

Abbott Laboratories
Baxter International Inc.
B Braun Melsungen AG
Danone Nutricia
Dr Reddy's Laboratories Ltd.
Mead Johnson & Company, LLC
Nestlé Health Science S.A.
Nutrego
Otsuka Holdings Co., Ltd.
Pfizer Inc.
Prohance
Victus, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical nutrition for diabetes care industry reached a revenue of USD 2.2 billion in 2023 and is anticipated to witness 4.8% CAGR from 2024 to 2032, primarily driven by the rising prevalence of diabetes and the increased awareness of the importance of nutrition in diabetes management.

The oral nutrition segment accounted for 65.2% of the market share in 2023, as they are more cost-effective than parenteral or enteral nutrition.

North America clinical nutrition for diabetes care industry accounted for USD 922.1 million in revenue in 2023 and may grow at 4.6% CAGR between 2024 – 2032, led by significant investments in diabetes management and related healthcare services.

Abbott Laboratories, Baxter International Inc., Danone Nutricia, Dr Reddy's Laboratories Ltd., Mead Johnson & Company, LLC, Nestlé Health Science S.A., Nutrego, Otsuka Holdings Co., Ltd., Pfizer Inc., Prohance, and Victus, Inc.